197 related articles for article (PubMed ID: 37300822)
1. Catalytic domain-dependent and -independent transcriptional activities of the tumour suppressor histone H3K27 demethylase UTX/KDM6A in specific cancer types.
Sun W; Lee KL; Poellinger L; Masai H; Kato H
Epigenetics; 2023 Dec; 18(1):2222245. PubMed ID: 37300822
[TBL] [Abstract][Full Text] [Related]
2. Lysine Demethylase KDM6A in Differentiation, Development, and Cancer.
Tran N; Broun A; Ge K
Mol Cell Biol; 2020 Sep; 40(20):. PubMed ID: 32817139
[TBL] [Abstract][Full Text] [Related]
3. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
4. The Histone Demethylase UTX Promotes Brown Adipocyte Thermogenic Program Via Coordinated Regulation of H3K27 Demethylation and Acetylation.
Zha L; Li F; Wu R; Artinian L; Rehder V; Yu L; Liang H; Xue B; Shi H
J Biol Chem; 2015 Oct; 290(41):25151-63. PubMed ID: 26306033
[TBL] [Abstract][Full Text] [Related]
5. UTX demethylase activity is required for satellite cell-mediated muscle regeneration.
Faralli H; Wang C; Nakka K; Benyoucef A; Sebastian S; Zhuang L; Chu A; Palii CG; Liu C; Camellato B; Brand M; Ge K; Dilworth FJ
J Clin Invest; 2016 Apr; 126(4):1555-65. PubMed ID: 26999603
[TBL] [Abstract][Full Text] [Related]
6. UTX Mutations in Human Cancer.
Wang L; Shilatifard A
Cancer Cell; 2019 Feb; 35(2):168-176. PubMed ID: 30753822
[TBL] [Abstract][Full Text] [Related]
7. A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.
Wang SP; Tang Z; Chen CW; Shimada M; Koche RP; Wang LH; Nakadai T; Chramiec A; Krivtsov AV; Armstrong SA; Roeder RG
Mol Cell; 2017 Jul; 67(2):308-321.e6. PubMed ID: 28732206
[TBL] [Abstract][Full Text] [Related]
8. The histone demethylase UTX/KDM6A in cancer: Progress and puzzles.
Schulz WA; Lang A; Koch J; Greife A
Int J Cancer; 2019 Aug; 145(3):614-620. PubMed ID: 30628063
[TBL] [Abstract][Full Text] [Related]
9. Histone demethylase UTX is a therapeutic target for diabetic kidney disease.
Chen H; Huang Y; Zhu X; Liu C; Yuan Y; Su H; Zhang C; Liu C; Xiong M; Qu Y; Yun P; Zheng L; Huang K
J Physiol; 2019 Mar; 597(6):1643-1660. PubMed ID: 30516825
[TBL] [Abstract][Full Text] [Related]
10. UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells.
Kim JH; Sharma A; Dhar SS; Lee SH; Gu B; Chan CH; Lin HK; Lee MG
Cancer Res; 2014 Mar; 74(6):1705-17. PubMed ID: 24491801
[TBL] [Abstract][Full Text] [Related]
11. The H3K27me3 demethylase UTX in normal development and disease.
Van der Meulen J; Speleman F; Van Vlierberghe P
Epigenetics; 2014 May; 9(5):658-68. PubMed ID: 24561908
[TBL] [Abstract][Full Text] [Related]
12. The C. elegans H3K27 demethylase UTX-1 is essential for normal development, independent of its enzymatic activity.
Vandamme J; Lettier G; Sidoli S; Di Schiavi E; Nørregaard Jensen O; Salcini AE
PLoS Genet; 2012; 8(5):e1002647. PubMed ID: 22570628
[TBL] [Abstract][Full Text] [Related]
13. Expression and significance of histone H3K27 demethylases in renal cell carcinoma.
Shen Y; Guo X; Wang Y; Qiu W; Chang Y; Zhang A; Duan X
BMC Cancer; 2012 Oct; 12():470. PubMed ID: 23057811
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.
Yi J; Shi X; Xuan Z; Wu J
Cancer Lett; 2021 Feb; 499():188-200. PubMed ID: 33253789
[TBL] [Abstract][Full Text] [Related]
15. UTX condensation underlies its tumour-suppressive activity.
Shi B; Li W; Song Y; Wang Z; Ju R; Ulman A; Hu J; Palomba F; Zhao Y; Le JP; Jarrard W; Dimoff D; Digman MA; Gratton E; Zang C; Jiang H
Nature; 2021 Sep; 597(7878):726-731. PubMed ID: 34526716
[TBL] [Abstract][Full Text] [Related]
16. The Loss of H3K27 Histone Demethylase Utx in T Cells Aggravates Allergic Contact Dermatitis.
Inoue T; Omori-Miyake M; Maruyama S; Okabe M; Kuwahara M; Honda H; Miura H; Yamashita M
J Immunol; 2021 Nov; 207(9):2223-2234. PubMed ID: 34588217
[TBL] [Abstract][Full Text] [Related]
17. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.
Rath BH; Waung I; Camphausen K; Tofilon PJ
Mol Cancer Ther; 2018 May; 17(5):1070-1078. PubMed ID: 29483212
[TBL] [Abstract][Full Text] [Related]
19. Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.
Kato H; Asamitsu K; Sun W; Kitajima S; Yoshizawa-Sugata N; Okamoto T; Masai H; Poellinger L
Oncogene; 2020 Apr; 39(16):3322-3335. PubMed ID: 32071397
[TBL] [Abstract][Full Text] [Related]
20. UTX-1 regulates Tat-induced HIV-1 transactivation via changing the methylated status of histone H3.
Zhang HS; Du GY; Liu Y; Zhang ZG; Zhou Z; Li H; Dai KQ; Yu XY; Gou XM
Int J Biochem Cell Biol; 2016 Nov; 80():51-56. PubMed ID: 27671333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]